MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Chronic Lymphocytic Leukemia Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,742 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,742 works in the cohort · of 4,299,418page 33 of 35

Labels cover 5 of 1,742 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,742 of 1,742 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

aboutno affunlabeled
Acalabrutinib (Calquence)
CDA-AMC
2025· article· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affunlabeled
MPL_risk.tex
Martin Boyer, Philippe D'Astous, Pierre‐Carl Michaud
2020· dataset· en· Harvard Dataverse· Medicine
machine prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
venueno affno abstractunlabeled
10.1016/b978-2-294-76306-9.50353-7
2000· book-chapter· en· Time to knit· Medicine
machine prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
affunlabeled
hive-24hr
Xu Zhao, Kirk Rodrigues, Yu Luo, Ding Yuan, Michael Stumm
2022· dataset· en· Zenodo (CERN European Organization for Nuclear Research)· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affunlabeled
Résultats actualisés d’une l’étude de phase Ib/II chez des patients atteints de lymphome diffus à grandes cellules B (LDGCB) en rechute/réfractaire (R/R) traités par polatuzumab vedotin (Pola) plus bendamustine (B) et rituximab (R) ou obinutuzumab (G)
Fabrice Jardin, Laurie H. Sehn, Alex F. Herrera, Matthew J. Matasar, Manali Kamdar, Sarit Assouline +9 more
2019· preprint· fr· HAL (Le Centre pour la Communication Scientifique Directe)· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affunlabeled
hive-24hr
Xu Zhao, Kirk Rodrigues, Yu Luo, Ding Yuan, Michael Stumm
2022· dataset· en· Zenodo (CERN European Organization for Nuclear Research)· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affvenueunlabeled
Improvements in BILAG Musculoskeletal and Mucocutaneous Domains at Week 48 in a Phase 2 Double-Blind Placebo-Controlled Trial of ABBV-599 (Elsubrutinib + Upadacitinib Combination) and Upadacitinib Monotherapy for Treatment of Moderately to Severely Active Systemic Lupus Erythematosus
Zahi Touma, Amit Saxena, Edward M Vital, Eric F. Morand, Marta Mosca, Kristin M. D’Silva +5 more
2025· article· en· The Journal of Rheumatology· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Aflibercept 8 mg/0.07 mL (Eylea HD)
CDA-AMC
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
← previousnext →

How this was built: Screen · Findings · About